Literature DB >> 22989607

Incident thromboembolism and heart failure associated with new-onset atrial fibrillation in cancer patients.

Yu-feng Hu, Chia-jen Liu, Peter Mu-hsin Chang, Hsuan-ming Tsao, Yenn-jiang Lin, Shih-lin Chang, Li-wei Lo, Ta-chuan Tuan, Cheng-hung Li, Tze-fan Chao, Fa-po Chung, Jo-nan Liao, Tzeng-Ji Chen, Shih-ann Chen.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22989607     DOI： 10.1016/j.ijcard.2012.08.036

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN： 0167-5273            Impact factor:   4.164


× No keyword cloud information.
  43 in total

Review 1.  Epidemiology of Atrial Fibrillation in the 21st Century: Novel Methods and New Insights.

Authors:  Jelena Kornej; Christin S Börschel; Emelia J Benjamin; Renate B Schnabel
Journal:  Circ Res       Date:  2020-06-18       Impact factor: 17.367

Review 2.  An update on cardio-oncology.

Authors:  Joerg Herrmann; Amir Lerman
Journal:  Trends Cardiovasc Med       Date:  2014-07-22       Impact factor: 6.677

Review 3.  Use of Direct Oral Anticoagulants in Patients with Cancer: Practical Considerations for the Management of Patients with Nausea or Vomiting.

Authors:  Hanno Riess; Cihan Ay; Rupert Bauersachs; Cecilia Becattini; Jan Beyer-Westendorf; Francis Cajfinger; Ian Chau; Alexander T Cohen; Alok A Khorana; Anthony Maraveyas; Marcos Renni; Annie M Young
Journal:  Oncologist       Date:  2018-04-12

Review 4.  Anticoagulation Strategies in Patients With Cancer: JACC Review Topic of the Week.

Authors:  Ramya C Mosarla; Muthiah Vaduganathan; Arman Qamar; Javid Moslehi; Gregory Piazza; Robert P Giugliano
Journal:  J Am Coll Cardiol       Date:  2019-03-26       Impact factor: 24.094

Review 5.  Anticoagulation of Cardiovascular Conditions in the Cancer Patient: Review of Old and New Therapies.

Authors:  Isaac B Rhea; Alexander R Lyon; Michael G Fradley
Journal:  Curr Oncol Rep       Date:  2019-04-04       Impact factor: 5.075

Review 6.  Cardiovascular Complications of Cancer Therapy: Best Practices in Diagnosis, Prevention, and Management: Part 2.

Authors:  Hui-Ming Chang; Tochukwu M Okwuosa; Tiziano Scarabelli; Rohit Moudgil; Edward T H Yeh
Journal:  J Am Coll Cardiol       Date:  2017-11-14       Impact factor: 24.094

Review 7.  How I manage ibrutinib intolerance and complications in patients with chronic lymphocytic leukemia.

Authors:  Deborah M Stephens; John C Byrd
Journal:  Blood       Date:  2019-01-14       Impact factor: 22.113

8.  Thirty-day mortality in ED patients with new onset atrial fibrillation and actively treated cancer.

Authors:  Thomas Lardaro; Wesley H Self; Tyler W Barrett
Journal:  Am J Emerg Med       Date:  2015-07-21       Impact factor: 2.469

Review 9.  Atrial Fibrillation and Stroke Risk in Patients With Cancer: A Primer for Oncologists.

Authors:  Marc Sorigue; Milos D Miljkovic
Journal:  J Oncol Pract       Date:  2019-12       Impact factor: 3.840

10.  The Impact of Cancer on Major Bleeding and Stroke/Systemic Emboli in Patients Using Direct Oral Anticoagulants:From the Database of a Single-Center Registry.

Authors:  Takao Sato; Yoshifusa Aizawa; Koichi Fuse; Satoshi Fujita; Yoshio Ikeda; Hitoshi Kitazawa; Minoru Takahashi; Masaaki Okabe
Journal:  J Atr Fibrillation       Date:  2018-12-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.